Related Items
Report: I.T. to Spur Rx Advances
June 23, 2008
Computer technologies will enable pharmaceutical manufacturers to dramatically shorten the research and development processes, increase success rates and cut clinical trial costs by 2020, according to a new report from PricewaterhouseCoopers, a New York-based consulting firm.
The use of computerized, “virtual” individuals will enable researchers to predict the effects of new drug candidates before testing in human beings, authors predict in the report.
Authors also predict that the inefficient practice of conducting clinical trials at multiple sites will be replaced with one or two “super centers” in each nation that will recruit patients and manage trials. But success of these centers presumes a wider adoption of standards-based electronic data interchange and electronic health records.
Incremental improvements in research and development are no longer enough for drug manufacturers as they face expiring patents within a few years on many drugs launched in the 1990s, according to the report. Only four of the top 10 companies have enough products in their pipelines to cover the impending revenue gap.
The full report, “Pharma 2020: Virtual R&D, which path will you take?” is available for free at pwc.com/pharma.
Business Intelligence Archive
Data Repositories Archive
Disease Management Archive
Electronic Data Interchange Archive
Electronic Health Records Archive
I.T. Spotlights
- About Us
- Advertising/Media Kit
- Reprints
- Editorial Calendar
- Contact Us
- Customer Service
- Privacy Statement
©2008 HealthDataManagement and SourceMedia, Inc. All rights reserved.
SourceMedia is an Investcorp company.
Use, duplication, or sale of this service, or data contained herein, is strictly prohibited.
